home / stock / xrtxf / xrtxf news

XRTXF News and Press, XORTX Therapeutics Inc From 07/14/21

Stock Information
Company Name: XORTX Therapeutics Inc
Stock Symbol: XRTXF
Market: OTC
Website: xortx.com
Menu
XRTXF XRTXF Quote XRTXF Short XRTXF News XRTXF Articles XRTXF Message Board
Get XRTXF Alerts

News, Short Squeeze, Breakout and More Instantly...
XRTXF - XORTX Therapeutics Strengthens Executive Team

CALGARY, Alberta, July 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that M...
XRTXF - Dr. Stephen Haworth Joins XORTX Management Team

● Dr. Haworth Appointed Chief Medical Officer ● CALGARY, Alberta, June 30, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical therapeutics company focused on developing innovative therap...

XRTXF - XORTX Welcomes Jaqueline Le Saux to Board of Directors

CALGARY, Alberta, June 17, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biotechnology company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the appoi...

XRTXF - XORTX Welcomes New Member to Board of Directors

CALGARY, Alberta, May 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biotechnology company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the appoin...
XRTXF - XORTX Announces Notice to Grant European Patent

CALGARY, Alberta, April 06, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing therapeutics for the treatment of progressive kidney disease, is pleased to announce that it has...

XRTXF - Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations an...

XRTXF - XORTX to Present at "Zoom With LD MICRO"

CALGARY, Alberta, March 16, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces its participation...
XRTXF - XORTX to Present and Participate in the Sachs 14th Annual European Life Sciences CEO Forum 2021

CALGARY, Alberta, March 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces its participation...

XRTXF - XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection

● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on develo...

XRTXF - XORTX Confirms $1 Million in Warrant Exercise Proceeds

CALGARY, Alberta, March 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce that...
Previous 10 Next 10